Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 127666-99-3 | 2-Chloro-4-methoxybenzonitrile | C8H6ClNO |
| 127667-00-9 | 2-Chloro-5-methoxybenzonitrile | C8H6ClNO |
| 127667-01-0 | 2-Fluoro-5-methoxybenzonitrile | C8H6FNO |
| 127667-44-1 | 4,4'-[1,3-Phenylenebis(1-methyl-ethylidene)]bisphenyl cyanate | C26H24O2N2 |
| 127675-46-1 | 3-Chloro-2,4-difluorobenzaldehyde | C7H3ClF2O |
| 127682-08-0 | L-2-Furylalanine hydrochloride | C7H9NO3.HCl |
| 127684-08-6 | 7-Ketocholesterol-D7 | C27H37D7O2 |
| 127687-08-5 | Bastadin 10 | C34H28Br4N4O9 |
| 127702-66-3 | (R)-4-Hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxododecyl)oxy]methyl]-3,5,8-trioxa-4-phosphadocosan-1-aminium inner salt 4-oxide | C34H68NO8P |
| 127702-67-4 | (R)-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-3,5,9-trioxa-4-phosphatricosan-1-aminium inner salt 4-oxide | C34H68NO8P |
| 127723-77-7 | 2-Fluoronitrobenzene labeled with carbon-14 | C6H4FNO2 |
| 127724-75-8 | 3-Chloro-7,8-dihydroquinolin-5(6H)-one | C9H8ClNO |
| 127733-39-5 | (S)-1-[2-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127733-40-8 | (S)-1-[3,5-Bis(trifluoromethyl)phenyl)ethylamine | C10H9F6N |
| 127733-42-0 | (R)-1-(2-Chlorophenyl)ethylamine | C8H10ClN |
| 127733-46-4 | (R)-1-[2-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127733-47-5 | (R)-1-[3,5-Bis(trifluoromethyl)phenyl)ethylamine | C10H9F6N |
| 127733-92-0 | Dihydrogenated tallow phthalic acid amide | |
| 127733-97-5 | (SP-4-1)-Tetraammineplatinum diacetate | 2(C2H3O2).H12N4Pt |
| 127733-98-6 | Tetraammineplatinum(II) hydrogen phosphate | (NH3)4.PtHPO4 |
| 127751-08-0 | Tetrakis(2-propynyloxymethyl) methane | C17H20O4 |
| 127753-52-0 | 3'-Azido-3'-deoxythymidine 5'-(tetrahydrogen triphosphate) compd. with N,N-diethylethanamine (1:3) | C10H16N5O13P3.3(C6H15N) |
| 127759-89-1 | Lobucavir | C11H15N5O3 |
| 127779-20-8 | Saquinavir | C38H50N6O5 |
| 127780-16-9 | Pantoprazole sulfone | C16H15F2N3O5S |
| 127785-96-0 | 6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate | C15H16N2.C4H4O4 |
| 127786-29-2 | Epinastine hydrobromide | C16H15N3.HBr |
| 127791-54-2 | (2E)-3-(3,5-Dihydroxyphenyl)-2-propenoic acid | C9H8O4 |
| 127792-23-8 | 2-[(2-Bromo-6-chlorophenyl)amino]benzeneacetic acid | C14H11BrClNO2 |
| 127792-49-8 | 2-Bromo-5-chlorobenzeneacetonitrile | C8H5BrClN |
| 127799-54-6 | 2-Methylhydrazinecarboxylic acid tert-butyl ester | C6H14N2O2 |
| 127817-85-0 | 4-Methoxy-2-(trifluoromethyl)benzoic acid | C9H7F3O3 |
| 127818-58-0 | 3-Methyl-5-nitrophenol | C7H7NO3 |
| 127827-52-5 | 6-Bromo-7-fluoroquinoline | C9H5BrFN |
| 127827-54-7 | 6-Bromo-7-chloroquinoline | C9H5BrClN |
| 127828-22-2 | tert-Butyl [2-(2-aminoethoxy)ethyl]carbamate | C9H20N2O3 |
| 127830-16-4 | Acid Brown 402 | |
| 127842-54-0 | 3,4-Bis(difluoromethoxy)benzaldehyde | C9H6F4O3 |
| 127852-21-5 | (S)-1-[3-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127852-22-6 | (S)-1-(3-Cyanophenyl)ethylamine | C9H10N2 |
| 127852-24-8 | (+)-(R)-1-(3-Trifluoromethylphenyl)ethanol | C9H9F3O |
| 127852-27-1 | (S)-1-[(2-Trifluoromethyl)phenyl]ethanol | C9H9F3O |
| 127852-28-2 | (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol | C10H8F6O |
| 127852-29-3 | (R)-1-[2-(Trifluoromethyl)phenyl]ethanol | C9H9F3O |
| 127852-30-6 | (R)-1-[3-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127852-31-7 | (R)-3-(1-Aminoethyl)benzonitrile | C9H10N2 |
| 127862-89-9 | (alphaS)-alpha-[[(Phenylmethoxy)carbonyl]amino]benzenebutanoic acid | C18H19NO4 |
| 127869-51-6 | Human C-type natriuretic peptide(1-22) | C93H157N27O28S3 |
| 127892-62-0 | 4-Chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acid | C7H9ClN2O2 |
| 127910-31-0 | (3E)-2-Amino-4-methyl-5-phosphono-3-pentenoic acid | C6H12NO5P |